The stock of UnitedHealth Group Inc (NYSE:UNH) reached all time high today, Nov, 25 and still has $162.22 target or 6.00% above today’s $153.04 share price. This indicates more upside for the $146.89 billion company. This technical setup was reported by Barchart.com. If the $162.22 PT is reached, the company will be worth $8.81 billion more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events. About 372,276 shares traded hands. UnitedHealth Group Inc (NYSE:UNH) has risen 14.47% since April 22, 2016 and is uptrending. It has outperformed by 9.06% the S&P500.
Analysts await UnitedHealth Group Inc (NYSE:UNH) to report earnings on January, 17. They expect $2.07 EPS, up 47.86% or $0.67 from last year’s $1.4 per share. UNH’s profit will be $1.99B for 18.48 P/E if the $2.07 EPS becomes a reality. After $2.17 actual EPS reported by UnitedHealth Group Inc for the previous quarter, Wall Street now forecasts -4.61% negative EPS growth.
UnitedHealth Group Inc (NYSE:UNH) Ratings Coverage
Out of 15 analysts covering UnitedHealth Group (NYSE:UNH), 14 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 93% are positive. UnitedHealth Group has been the topic of 20 analyst reports since September 2, 2015 according to StockzIntelligence Inc. The stock of UnitedHealth Group Inc (NYSE:UNH) earned “Outperform” rating by Credit Suisse on Wednesday, December 16. On Wednesday, September 2 the stock rating was upgraded by Vetr to “Strong-Buy”. FBR Capital maintained UnitedHealth Group Inc (NYSE:UNH) rating on Thursday, November 19. FBR Capital has “Outperform” rating and $130 price target. The stock of UnitedHealth Group Inc (NYSE:UNH) earned “Overweight” rating by JP Morgan on Wednesday, September 16. The stock has “Buy” rating given by Mizuho on Friday, November 20. The firm has “Neutral” rating by Mizuho given on Wednesday, November 9. The stock of UnitedHealth Group Inc (NYSE:UNH) has “Buy” rating given on Friday, October 2 by Citigroup. The company was reinitiated on Wednesday, September 9 by Morgan Stanley. Cleveland initiated the shares of UNH in a report on Friday, April 8 with “Buy” rating. The rating was initiated by Bernstein with “Outperform” on Thursday, June 16.
According to Zacks Investment Research, “UnitedHealth Group Inc. offers health care coverage and related services to help people achieve improved health and well-being through all stages of life. The company’s products and services reflect a number of core capabilities, including medical information management, health benefit administration, care coordination, risk assessment and pricing, health benefit design and provider contracting. With these capabilities, it is able to provide comprehensive health care management services through organized health systems and insurance products.”
Insitutional Activity: The institutional sentiment increased to 1.02 in 2016 Q2. Its up 0.10, from 0.92 in 2016Q1. The ratio increased, as 55 funds sold all UnitedHealth Group Inc shares owned while 466 reduced positions. 94 funds bought stakes while 386 increased positions. They now own 805.88 million shares or 5.42% less from 852.02 million shares in 2016Q1.
Wms Prtn Lc owns 2,469 shares or 0.05% of their US portfolio. Cadence Retail Bank Na has 0.3% invested in the company for 4,260 shares. Northern Management Lc has 5,875 shares for 0.37% of their US portfolio. The Japan-based Daiwa Secs Group Inc has invested 0.17% in UnitedHealth Group Inc (NYSE:UNH). Parametric Portfolio Limited Company has 2.72 million shares for 0.61% of their US portfolio. Moreover, Investors Advisory has 0.08% invested in UnitedHealth Group Inc (NYSE:UNH) for 3,053 shares. Kornitzer Capital Ks owns 3,350 shares or 0.01% of their US portfolio. Balyasny Asset Mngmt Ltd Liability Corp last reported 0.24% of its portfolio in the stock. Inv Centers Of America last reported 0.06% of its portfolio in the stock. Regentatlantic Capital Ltd Liability holds 1.27% of its portfolio in UnitedHealth Group Inc (NYSE:UNH) for 93,460 shares. Thomas White Intl has 0.32% invested in the company for 15,281 shares. Babson Limited has invested 0.42% of its portfolio in UnitedHealth Group Inc (NYSE:UNH). Greenwich Wealth Ltd Liability has 0.07% invested in the company for 25,200 shares. The United Kingdom-based Origin Asset Mngmt Limited Liability Partnership has invested 2.47% in UnitedHealth Group Inc (NYSE:UNH). Daniel Devine & Communication has 15,065 shares for 1.45% of their US portfolio.
Insider Transactions: Since June 10, 2016, the stock had 0 insider purchases, and 6 sales for $9.57 million net activity. 14,365 shares were sold by WILSON D ELLEN, worth $2.07M on Friday, October 21. 40,000 UnitedHealth Group Inc (NYSE:UNH) shares with value of $5.41 million were sold by BURKE RICHARD T. The insider BALLARD WILLIAM C JR sold $453,615. Another trade for 5,500 shares valued at $768,924 was made by WILENSKY GAIL R on Friday, June 10. On Friday, October 21 the insider Shine Kenneth Irwin sold $47,121.
More news for UnitedHealth Group Inc (NYSE:UNH) were recently published by: Businesswire.com, which released: “UnitedHealth Group to Host Investor Conference” on November 21, 2016. Forbes.com‘s article titled: “December 9th Options Now Available For UnitedHealth Group (UNH)” and published on October 27, 2016 is yet another important article.
UNH Company Profile
UnitedHealth Group Incorporated, incorporated on January 25, 1977, is a health and well-being company. The Companyâ€™s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various clients and markets. Optum is a health services business serving the health care marketplace, including payers, care providers, employers, Governments, life sciences companies and consumers. The Companyâ€™s business platforms have four divisions: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.